MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX), a global leader in women's health, will launch the NovaSure® V5 global endometrial ablation (GEA) device at the American Association ...

ARLINGTON, Va.--(BUSINESS WIRE)--The National Evaluation System for health Technology (NEST), an initiative of the Medical Device Innovation Consortium (MDIC), is pleased to welcome Hologic, a leading ...

On Friday, the FDA warned against using Hologic Inc.’s (NASDAQ:HOLX) BioZorb Marker products and urged healthcare facilities to return all unused lots. This follows Hologic’s voluntary recall of the ...

A new private-label deal will see Hologic Inc. distributing a soft tissue biopsy instrument manufactured by Angiotech Pharmaceuticals Inc. Angiotech Pharmaceuticals Inc. (NSDQ:ANPI) inked a three-year ...

-- Transaction Further Diversifies Hologic’s Product Offering and Broadens Access to Bolder Devices -- “This acquisition will broaden our growing Surgical portfolio by adding Bolder’s differentiated ...

While the company no longer manufactures the radiographic markers, healthcare providers are still advised to monitor patients who have had them implanted.

Add Yahoo as a preferred source to see more of our stories on Google. The headquarters of the U.S. Food and Drug Administration (FDA) is seen in Silver Spring, Maryland (Reuters) - The U.S. health ...

CINCINNATI, Ohio — Ethicon Endo-Surgery Inc. and a subsidiary of Hologic Inc. have settled their patent infringement disagreements with a $12.5 million payment to Ethicon and the promise to share ...

Marlborough-based medical device manufacturer Hologic has been issued a warning letter from the U.S. Food and Drug Administration concerning its BioZorb Marker, a device originally recalled in March.

A medtech expert explains why a recall is a quality event and a national shortage is a design decision made years earlier.

Over the last 20 years, the NovaSure system has built a trusted legacy in GEA. The NovaSure device first received FDA approval in 2001, and by 2018 the NovaSure procedure had been used to treat over 3 ...